As such, we would like to recommend that genetic screenings in women with GDM should include PAX4, HMG20A and PAX8 to resolutely establish the correlation of genetic variants with this form of diabetes and potentially develop personalized therapy targeting specific pathways implicated in islet mass expansion/survival including potentiating the inflammatory response. This evidence concerns the gene PAX4 and diabetes mellitus.